BIO KEY INTERNATIONAL INC
For the period ended Oct 30, 2026. Filed Oct 30, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 30, 2026 · Filed Oct 30, 2026
Use the contents to explore the available documents and sections.
Contents
PROXY STATEMENT
proxy statement on Schedule 14A, filed with the SEC on July 24, 2026 (the “Proxy Statement”), and the supplement to the Proxy Statement filed with the SEC on August 24, 2026 (the “Supplement”).
Proposal 4, which sought stockholder approval, for purposes of complying with Nasdaq Listing Rule 5635(d), of the issuance of up to 1,236,668 shares of the Company’s common stock upon the exercise of warrants issued in the Company’s August 10, 2026 warrant inducement transaction, was approved, and the final voting results were as follows:
| Votes For | Votes Against | Abstentions | Broker Non-Votes |
|---|---|---|---|
| 129,795 | 89,849 | 648 | 0 |
No other matters were submitted to a vote at the reconvened Annual Meeting, and the Annual Meeting was concluded.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BIO-KEY INTERNATIONAL, INC. | ||
| Date: October 30, 2026 | By: | /s/ Cecilia C. Welch |
|---|---|---|
| Cecilia C. Welch | ||
| Chief Financial Officer | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.